|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 4 of 179 found articles
| Title: |
LBA1 Interim results of a phase I/Ib study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib (RIB) or alpelisib (ALP) in patients with ER+ breast cancer (BC) who had progressed after endocrine therapy (ET) |
| Author: |
Jhaveri, K. Juric, D. Yap, Y-S. Cresta, S. Layman, R. Duhoux, F. Terret, C. De Vita, S. Kundamal, N. He, W. Balbin, A. Sheng, Q. Crystal, A. Curigliano, G. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 31 () nr. S2 pages S62 |
| Year: |
2020 |
| Contents: | |
| Publisher: |
The Authors |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 4 of 179 found articles
| << previous | next >> |